Mutant B-RAF-Mcl-1 survival signaling depends on the STAT3 transcription factor

- Becker, T. M., Boyd, S. C., Rizos, H., Mijatov, B., Gowrishankar, K., Snoyman, S., Pupo, G. M., Scolyer, R. A., Mann, G. J., Kefford, R. F., Zhang, X. D.

Oncogenic suppression of PHLPP1 in human melanoma

- Dong, L., Jin, L., Guo, S. T., Tseng, H-Y., Wang, C. Y., Wilmott, J. S., Yosufi, B., Yan, X. G., Jiang, C. C., Scolyer, R. A., Zhang, X. D.

Oncogenic suppression of PHLPP1 in human melanoma

- Dong, L., Jin, L., Guo, S. T., Tseng, H-Y., Wang, C. Y., Wilmott, J. S., Yosufi, B., Yan, X. G., Jiang, C. C., Scolyer, R. A., Zhang, X. D.

AEBP1 upregulation confers acquired resistance to BRAF (V600E) inhibition in melanoma

- Hu, W., Jin, L., Jiang, C. C., Long, G. V., Scolyer, R. A., Wu, Q., Zhang, X. D., Mei, Y., Wu, M.